Clinical Cancer Research CR Helping Patients Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Passebosc-Faure, K.
Right arrow Articles by Genin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Passebosc-Faure, K.
Right arrow Articles by Genin, C.
Clinical Cancer Research Vol. 11, 6862-6867, October 1, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Evaluation of a Panel of Molecular Markers for the Diagnosis of Malignant Serous Effusions

Karine Passebosc-Faure1, Guorong Li1, Claude Lambert1, Michèle Cottier3, Anne Gentil-Perret4, Pierre Fournel2, Maurice Pérol5 and Christian Genin1

Authors' Affiliations: Departments of 1 Immunology, 2 Pneumology, 3 Cytology, 4 Pathology, University Hospital Center, Saint Etienne, France and 5 Department of Pneumology, University Hospital Center, Lyon, France

Requests for reprints: Christian Genin, Department of Immunology, Bellevue University Hospital Center, University of Saint Etienne, Bd Pasteur, Pavillon 5 Bis, 42055 Saint Etienne, France. Phone: 33-4-77-82-83-79; Fax: 33-4-77-82-84-93; E-mail: Christian.Genin{at}univ-st-etienne.fr.

Purpose: Our main goal was to evaluate a panel of molecular markers for the detection of cancer cells in serous effusions and to determine their value as an adjunctive reverse transcription-PCR (RT-PCR) test to cytologic examination.

Experimental Design: One hundred fourteen serous effusions from 71 patients with tumors and 43 patients with benign diseases were subjected to RT-PCR for expression of carcinoembryonic antigen (CEA), epithelial cell adhesion molecule (Ep-CAM), E-cadherin, mammaglobin, mucin 1 (MUC1) isoforms MUC1/REP, MUC1/Y, and MUC1/Z, calretinin, and Wilms' tumor 1 susceptibility gene.

Results: CEA, Ep-CAM, E-cadherin, and mammaglobin were specifically expressed in malignant effusions. The sensitivity of RT-PCR in cytologically negative malignant effusions was 63.1% combining CEA and Ep-CAM (with 100% specificity) and reached 78.9% adding MUC1/Y or MUC1/Z (with 93% specificity). In the whole population of effusions, the combination of cytology with RT-PCR of CEA and Ep-CAM yielded a 90.1% sensitivity, a specificity and a positive predictive value of 100%, and a 86% negative predictive value for malignancy. Adding MUC1/Y or MUC1/Z to the panel, the sensitivity was 94.5% with 93% specificity, 95.7% PPV, and 90.9% negative predictive value. Moreover, CEA and mammaglobin were specifically expressed in epithelial malignancies, and mammaglobin was mainly expressed in effusions from breast carcinoma (97.3% of specificity).

Conclusions: A combination of cytology and RT-PCR analysis of CEA and Ep-CAM significantly improved the detection sensitivity of tumor cells in serous effusions. RT-PCR analysis of CEA, Ep-CAM, and mammaglobin in serous effusions could be a beneficial adjunct to cytology for the diagnosis of malignancy.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. C. Workman, C. Sweeney, and K. L. Carraway III
The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms
Cancer Res., April 1, 2009; 69(7): 2845 - 2852.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Elia, R. Massoud, G. Guggino, B. Cristino, C. Cortese, A. R. De Massimi, and R. Zenobi
Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures
Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 723 - 727.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
F C Schmitt, A Longatto-Filho, A Valent, and P Vielh
Molecular techniques in cytopathology practice
J. Clin. Pathol., March 1, 2008; 61(3): 258 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
F. Hube, Y. Myal, E. Leygue, J. Rollin, Y. Gruel, Y. Yatabe, and on behalf of the authors
Expression of Two Breast-Specific Molecules in the Lung
J. Mol. Diagn., July 1, 2006; 8(3): 390 - 393.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.